Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 3, 2024
Abstract
Recently,
multi-drug
resistant
(MDR)
bacteria
are
responsible
for
a
large
number
of
infectious
diseases
that
can
be
life-threatening.
Globally,
new
approaches
targeted
to
solve
this
essential
issue.
This
study
aims
discover
novel
antibiotic
alternatives
by
using
the
whole
components
biofilm
layer
as
macromolecule
synthesize
silver
nanoparticles
(AgNPs)
promising
agent
against
MDR.
In
particular,
biosynthesized
biofilm-AgNPs
were
characterized
UV-Vis
spectroscopy,
electron
microscopes,
Energy
Dispersive
X-ray
(EDX),
zeta
sizer
and
potential
while
their
effect
on
bacterial
strains
normal
cell
lines
was
identified.
Accordingly,
have
lavender-colored
solution,
spherical
shape,
with
size
range
20–60
nm.
Notably,
they
inhibitory
effects
when
used
various
concentrations
ranging
between
12.5
25
µg/mL.
addition,
an
effective
synergistic
combined
phage
ZCSE9
inhibit
kill
Salmonella
enterica
concentration
3.1
conclusion,
work
presents
biosynthesis
preparation
AgNPs
antibacterial
purposes
reduce
possible
toxicity
reducing
MICs
ZCSE9.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(10), P. 5465 - 5465
Published: May 17, 2024
Wound
infection
is
one
of
the
most
important
factors
affecting
wound
healing,
so
its
effective
control
critical
to
promote
process
healing.
However,
with
increasing
prevalence
multi-drug-resistant
(MDR)
bacterial
strains,
prevention
and
treatment
infections
are
now
more
challenging,
imposing
heavy
medical
financial
burdens
on
patients.
Furthermore,
diminishing
effectiveness
conventional
antimicrobials
declining
research
new
antibiotics
necessitate
urgent
exploration
alternative
treatments
for
infections.
Recently,
phage
therapy
has
been
revitalized
as
a
promising
strategy
address
challenges
posed
by
in
era
antibiotic
resistance.
The
use
treating
infectious
diseases
demonstrated
positive
results.
This
review
provides
an
overview
mechanisms,
characteristics,
delivery
methods
combating
pathogenic
bacteria.
Then,
we
focus
clinical
application
various
therapies
managing
refractory
infections,
such
diabetic
foot
well
traumatic,
surgical,
burn
Additionally,
analysis
potential
obstacles
practice
presented,
along
corresponding
strategies
addressing
these
issues.
serves
enhance
our
understanding
innovative
avenues
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(19), P. 12194 - 12209
Published: May 1, 2024
In
situ
vaccines
(ISVs)
utilize
the
localized
delivery
of
chemotherapeutic
agents
or
radiotherapy
to
stimulate
release
endogenous
antigens
from
tumors,
thereby
eliciting
systemic
and
persistent
immune
activation.
Recently,
a
bioinspired
ISV
strategy
has
attracted
tremendous
attention
due
its
features
such
as
an
adjuvant
effect
genetic
plasticity.
M13
bacteriophages
are
natural
nanomaterials
with
intrinsic
immunogenicity,
flexibility,
cost-effectiveness
for
large-scale
production,
demonstrating
potential
application
in
cancer
vaccines.
this
study,
we
propose
based
on
engineered
bacteriophage
targeting
CD40
(M13CD40)
dendritic
cell
(DC)-targeted
stimulation,
named
H-GM-M13CD40.
We
induce
immunogenic
death
tumor
through
local
(S)-10-hydroxycamptothecin
(HCPT),
followed
by
intratumoral
injection
granulocyte-macrophage
colony
stimulating
factor
(GM-CSF)
M13CD40
enhance
DC
recruitment
demonstrate
that
can
result
significant
accumulation
activation
DCs
at
site,
reversing
immunosuppressive
microenvironment.
addition,
H-GM-M13CD40
synergize
PD-1
blockade
abscopal
effects
cold
models.
Overall,
our
study
verifies
immunogenicity
provides
proof
concept
phage
function
ISVs.
The ISME Journal,
Journal Year:
2024,
Volume and Issue:
18(1)
Published: Jan. 1, 2024
The
prokaryotic
adaptive
immune
system,
CRISPR-Cas
(clustered
regularly
interspaced
short
palindromic
repeats;
CRISPR-associated),
requires
the
acquisition
of
spacer
sequences
that
target
invading
mobile
genetic
elements
such
as
phages.
Previous
work
has
identified
ecological
variables
drive
evolution
CRISPR-based
immunity
model
organism
Pseudomonas
aeruginosa
PA14
against
its
phage
DMS3vir,
resulting
in
rapid
extinction.
However,
it
is
unclear
if
and
how
stable
acquired
within
bacterial
populations,
this
depends
on
environment.
Here,
we
examine
dynamics
CRISPR
loss
over
a
30-day
experiment
identify
conditions
tip
balance
between
long-term
maintenance
versus
invasion
alternative
resistance
strategies
support
persistence.
Specifically,
find
both
initial
dose
reinfection
frequencies
determine
whether
or
not
maintained
long
term,
can
coexist
with
bacteria.
At
population
genetics
level,
emergence
are
associated
high
levels
diversity
subsequently
decline
due
to
bacteria
carrying
pilus-associated
mutations.
Together,
these
results
provide
resolution
demonstrate
cumulative
burden
determines
effectiveness
ecologically
relevant
timeframes.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: June 20, 2024
Abstract
Novel
therapeutic
strategies
against
difficult-to-treat
bacterial
infections
are
desperately
needed,
and
the
faster
cheaper
way
to
get
them
might
be
by
repurposing
existing
antibiotics.
Nanodelivery
systems
enhance
efficacy
of
antibiotics
guiding
their
targets,
increasing
local
concentration
at
site
infection.
While
recently
described
nanodelivery
promising,
they
generally
not
easy
adapt
different
lack
biocompatibility
or
specificity.
Here,
created
that
source
targeting
proteins
from
bacteriophages.
Bacteriophage
receptor-binding
cell-wall
binding
domains
conjugated
nanoparticles,
for
targeted
delivery
rifampicin,
imipenem,
ampicillin
pathogens.
They
show
excellent
specificity
accumulate
infection
deliver
antibiotic
payload.
Moreover,
suppress
pathogen
more
effectively
than
16
32-fold
higher
doses
free
This
study
demonstrates
bacteriophage
sourced
promising
candidates
guide
systems.
Their
specificity,
availability,
make
great
options
needed
combat
infections.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 3, 2024
Abstract
Recently,
multi-drug
resistant
(MDR)
bacteria
are
responsible
for
a
large
number
of
infectious
diseases
that
can
be
life-threatening.
Globally,
new
approaches
targeted
to
solve
this
essential
issue.
This
study
aims
discover
novel
antibiotic
alternatives
by
using
the
whole
components
biofilm
layer
as
macromolecule
synthesize
silver
nanoparticles
(AgNPs)
promising
agent
against
MDR.
In
particular,
biosynthesized
biofilm-AgNPs
were
characterized
UV-Vis
spectroscopy,
electron
microscopes,
Energy
Dispersive
X-ray
(EDX),
zeta
sizer
and
potential
while
their
effect
on
bacterial
strains
normal
cell
lines
was
identified.
Accordingly,
have
lavender-colored
solution,
spherical
shape,
with
size
range
20–60
nm.
Notably,
they
inhibitory
effects
when
used
various
concentrations
ranging
between
12.5
25
µg/mL.
addition,
an
effective
synergistic
combined
phage
ZCSE9
inhibit
kill
Salmonella
enterica
concentration
3.1
conclusion,
work
presents
biosynthesis
preparation
AgNPs
antibacterial
purposes
reduce
possible
toxicity
reducing
MICs
ZCSE9.